Category Archives: CEO

The Secret behind Securus Success- Rick Smith

There is nothing that boosts the performance of a company like good leadership. The chief executive officer of an organization plays a very significant role in the ranking of a company. This is why it is crucial to run a background check on the candidates of the post in a firm. Exclusive research of the individuals is also a requirement. This helps in ensuring that the decision is sound. There any firms whose course has changed positively after a new CEO takes over.

Securus Technologies has been on the top in the provision of high tech products. More than 3400 prominent businesses, 2600 correctional services and a 1000000 inmate’s rely on their services. This is because they have established themselves well in the industry. Their gadgets are convenient and reliable. This has only been possible with Rick Smith as the CEO.

Rick Smith assumed office in 2008. Since then the firm has gone through a positive reformation. It has become an asset to the society. Rick Smith has a lot of positive attributes that led to his appointment as the CEO of Securus Technologies. For instance, he has a clean criminal record, great leadership skills, long experience not to forget his rich educational background.

Academic Background

Education is key to success in running every business. It is, therefore, a mandatory requirement for a CEO. Without educational and the technical know-how of the field, so many things are bound to go wrong.

Rick Smith has a very affluent academic background. He has an undergraduate degree in Engineering and a master’s degree of the same. He also has a master’s degree in mathematics, not to forget he is an MBA holder.

All these courses were acquired from prestigious institutions. This skill assists him in understanding the basic concepts of running a company. It also aids in ensuring that the resources are well utilized and well distributed.

Rick Smiths Experience

The other factor that contributes to great leadership is the experience. This is because it gives the CEO tips on how to maximize profits. It also helps in dealing with off-peak seasons of business.

Rick Smith had worked in many organizations before joining Securus Technologies. The last firm he worked with was Eschelon-Telkom. Here he left a legacy by raising their revenue to $350 million from $30 million annually.

He had also worked in other institutions, in different departments before Eschelon. The knowledge of what goes on in every department gave him the understanding of the attention each one of them needs.

Conclusion

Rick Smith has made a difference in Securus Technologies. They are hopeful that he will continue leading the company towards success,

Based on his experience, they are confident that he was the right individual for this seat.

Mikhail Blagosklonny Says Rapamycin May Solve Disease & Aging Problems

According to Mikhail Blagosklonny, scientist, oncologist, professor, and Editor-in-Chief at Oncotarget says with age, the repair mechanisms of the body diminish. As a result, wear and tear increases and it increases the risk of diseases such as Alzheimer’s, diabetes or disorders of the cardiovascular system. Current therapies are based on treating these diseases, but if you ask Mikhail Blagosklonny, doctors should be consider a strategy that addresses aging, rather than age-related diseases. But how do you accomplish that?

Increasing Our Life Span

The drug Rapamycin is incredible, says Dr. Blagosklonny. It’s used in organ transplantation to keep the immune system in check, and thus can prevent rejection of foreign tissue. Scientists have demonstrated another effect, or an added bonus of Rapamycin. This drug was the first drug that has shown an effect on the maximum life span in mice, and has prompted additional clinical studies. Rapamycin also inhibits tumor formation.

“Aging is a complex process,” Dr. Mikhail Blagosklonny explains. “It causes so many changes in the cells, and organs, and behavior,” he added. Over the years, our body’s ability decreases to form new cells. Thus, the whole metabolism slows down. It is quite natural that many functions we take for granted slowly decrease. For example, eyesight and hearing: Over the years, the human is eye not as good in different lighting conditions. In addition, from about the age of 40 individuals can develop presbyopia. And the immune system doesn’t produce as many antibodies and new cells. Thus, older people are more likely to get sick and it is more common that it becomes severe over the course of the disease.

The Roswell Park Cancer Institute professor has been researching Rapamycin also known as Sirolimus for this revolutionary potential of slowing down the aging process. Clinical studies have shown that the life expectancy of treated mice increased by 14 percent. Currently, researchers at the University of Washington Seattle are testing Rapamycin on dogs. The search for drugs that slow the aging process is cumbersome in, but also promising. Dr. Blagosklonny says Rapamycin can be used to prevent restenosis, after a balloon angioplasty medical procedure. In fact, tests have showed that patients using the drug after their angioplasty procedure did not require a repeat of the procedure, due to the use of the drug.

Additionally, the drug inhibits cancerous tumors, while providing a boost to the immune system, which in turn, helps the body fight off the disease. Blagosklonny believes that if cell aging can stop, organs will work longer, enabling a longer lifespan.

Dr.MikhailBlagosklonny, a Professor of Oncology is a highly experienced researcher with an acclaimed career. After graduating with his M.D. and Ph.D. from the First Pavlov State Medical University of St. Petersburg, he moved to the United States, and worked at NY Medical College. He served as an Associate Professor of Medicine before being appointed Senior Scientist at Ordway Research Institute in 2002. After seven years, Dr. Blagosklonny left to become Professor of Oncology at Roswell Park Cancer Institute. Through his research there, he studies cancer and aging.